Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

Integrating Medical Humanities into medical school training.

Bifulco M, Pisanti S.

EMBO Rep. 2019 Oct 30:e48830. doi: 10.15252/embr.201948830. [Epub ahead of print]

PMID:
31663234
2.

N6-Isopentenyladenosine Inhibits Colorectal Cancer and Improves Sensitivity to 5-Fluorouracil-Targeting FBXW7 Tumor Suppressor.

Fiore D, Piscopo C, Proto MC, Vasaturo M, Dal Piaz F, Fusco BM, Pagano C, Laezza C, Bifulco M, Gazzerro P.

Cancers (Basel). 2019 Sep 28;11(10). pii: E1456. doi: 10.3390/cancers11101456.

3.

HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis.

Gentile MT, Pastorino O, Bifulco M, Colucci-D'Amato L.

J Vis Exp. 2019 Jun 24;(148). doi: 10.3791/58591.

PMID:
31282895
4.

Novel role for cannabidiol in circadian clock function.

Bifulco M, Navarra G, Laezza C, Pagano C.

Addict Biol. 2019 May 27:e12772. doi: 10.1111/adb.12772. [Epub ahead of print] No abstract available.

PMID:
31132803
5.

Trotula de Ruggiero: The Magistra mulier sapiens and her medical dermatology treatises.

Bifulco M, De Falco DD, Aquino RP, Pisanti S.

J Cosmet Dermatol. 2019 Feb 25. doi: 10.1111/jocd.12882. [Epub ahead of print]

PMID:
30803123
6.

The transition from adolescence to adulthood as a 'sensitive period' for developing cancer risk: the contribution of obesity and sociobehavioral mechanisms.

Bifulco M, Abate M.

Eur J Cancer Prev. 2019 Mar;28(2):142. doi: 10.1097/CEJ.0000000000000425. No abstract available.

PMID:
30707145
7.

Medical Cannabis: A plurimillennial history of an evergreen.

Pisanti S, Bifulco M.

J Cell Physiol. 2019 Jun;234(6):8342-8351. doi: 10.1002/jcp.27725. Epub 2018 Nov 11. Review.

PMID:
30417354
8.

PR/SET Domain Family and Cancer: Novel Insights from the Cancer Genome Atlas.

Sorrentino A, Federico A, Rienzo M, Gazzerro P, Bifulco M, Ciccodicola A, Casamassimi A, Abbondanza C.

Int J Mol Sci. 2018 Oct 19;19(10). pii: E3250. doi: 10.3390/ijms19103250.

9.

Symptoms of alcohol abuse: The first warning sign of cancer development risk.

Bifulco M, Citro M, Abate M.

Eur J Intern Med. 2018 Sep;55:e19-e20. doi: 10.1016/j.ejim.2018.07.003. Epub 2018 Jul 6. No abstract available.

PMID:
29983226
10.

Polypharmacological profile of 1,2-dihydro-2-oxo-pyridine-3-carboxamides in the endocannabinoid system.

Chicca A, Arena C, Bertini S, Gado F, Ciaglia E, Abate M, Digiacomo M, Lapillo M, Poli G, Bifulco M, Macchia M, Tuccinardi T, Gertsch J, Manera C.

Eur J Med Chem. 2018 Jun 25;154:155-171. doi: 10.1016/j.ejmech.2018.05.019. Epub 2018 May 14.

PMID:
29793210
11.

Colon Cancer Survival and Statins: What More Evidence Do We Need?

Bifulco M, Gazzerro P.

Gastroenterology. 2018 Apr;154(5):1545-1546. doi: 10.1053/j.gastro.2017.06.071. Epub 2018 Mar 8. No abstract available.

PMID:
29526725
12.

Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids.

Fiore D, Ramesh P, Proto MC, Piscopo C, Franceschelli S, Anzelmo S, Medema JP, Bifulco M, Gazzerro P.

Front Pharmacol. 2018 Jan 4;8:949. doi: 10.3389/fphar.2017.00949. eCollection 2017.

13.

The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cells.

Santoro A, Ciaglia E, Nicolin V, Pescatore A, Prota L, Capunzo M, Ursini MV, Nori SL, Bifulco M.

Inflamm Res. 2018 Apr;67(4):315-326. doi: 10.1007/s00011-017-1123-6. Epub 2017 Dec 11.

14.

Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma.

Abate M, Laezza C, Pisanti S, Torelli G, Seneca V, Catapano G, Montella F, Ranieri R, Notarnicola M, Gazzerro P, Bifulco M, Ciaglia E.

Sci Rep. 2017 Oct 26;7(1):14123. doi: 10.1038/s41598-017-14495-6.

15.

N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux.

Ranieri R, Ciaglia E, Amodio G, Picardi P, Proto MC, Gazzerro P, Laezza C, Remondelli P, Bifulco M, Pisanti S.

Cell Death Differ. 2018 Feb;25(2):353-367. doi: 10.1038/cdd.2017.165. Epub 2017 Oct 13.

16.

Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer.

Proto MC, Fiore D, Piscopo C, Franceschelli S, Bizzarro V, Laezza C, Lauro G, Feoli A, Tosco A, Bifulco G, Sbardella G, Bifulco M, Gazzerro P.

Sci Rep. 2017 Sep 15;7(1):11678. doi: 10.1038/s41598-017-11688-x.

17.

Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines.

Ciaglia E, Laezza C, Abate M, Pisanti S, Ranieri R, D'alessandro A, Picardi P, Gazzerro P, Bifulco M.

Int J Cancer. 2018 Jan 1;142(1):176-190. doi: 10.1002/ijc.31036. Epub 2017 Sep 21.

18.

Impact of drought on human health.

Bifulco M, Ranieri R.

Eur J Intern Med. 2017 Dec;46:e9-e10. doi: 10.1016/j.ejim.2017.08.009. Epub 2017 Aug 12. No abstract available.

PMID:
28807484
19.

Immuno-Modulatory and Anti-Inflammatory Effects of Dihydrogracilin A, a Terpene Derived from the Marine Sponge Dendrilla membranosa.

Ciaglia E, Malfitano AM, Laezza C, Fontana A, Nuzzo G, Cutignano A, Abate M, Pelin M, Sosa S, Bifulco M, Gazzerro P.

Int J Mol Sci. 2017 Jul 28;18(8). pii: E1643. doi: 10.3390/ijms18081643.

20.

Remembering Professor Gaetano "Nino" Salvatore.

Bifulco M.

Endocrine. 2018 Jul;61(1):173-174. doi: 10.1007/s12020-017-1376-4. Epub 2017 Aug 7. No abstract available.

PMID:
28786075
21.

The mystery of longevity in Cilento: a mix of a good dose of genetic predisposition and a balanced diet based on the Mediterranean model.

Bifulco M, Pisanti S.

Eur J Clin Nutr. 2017 Aug;71(8):1020-1021. doi: 10.1038/ejcn.2017.91. Epub 2017 May 31. No abstract available.

PMID:
28561040
22.

The isoprenoid derivative N6 -benzyladenosine CM223 exerts antitumor effects in glioma patient-derived primary cells through the mevalonate pathway.

Ciaglia E, Grimaldi M, Abate M, Scrima M, Rodriquez M, Laezza C, Ranieri R, Pisanti S, Ciuffreda P, Manera C, Gazzerro P, D'Ursi AM, Bifulco M.

Br J Pharmacol. 2017 Jul;174(14):2287-2301. doi: 10.1111/bph.13824. Epub 2017 Jun 11.

23.

Cannabidiol: State of the art and new challenges for therapeutic applications.

Pisanti S, Malfitano AM, Ciaglia E, Lamberti A, Ranieri R, Cuomo G, Abate M, Faggiana G, Proto MC, Fiore D, Laezza C, Bifulco M.

Pharmacol Ther. 2017 Jul;175:133-150. doi: 10.1016/j.pharmthera.2017.02.041. Epub 2017 Feb 22. Review.

PMID:
28232276
24.

Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15.

Malfitano AM, Laezza C, Bertini S, Marasco D, Tuccinardi T, Bifulco M, Manera C.

Biochimie. 2017 Apr;135:173-180. doi: 10.1016/j.biochi.2017.02.009. Epub 2017 Feb 20.

PMID:
28219703
25.

The complex interplay among hepatocytes and immune cells at the crossroad between inflammation and cholesterol metabolism in hyperglycemia.

Bifulco M, Pisanti S, Ciaglia E.

Endocrine. 2017 Oct;58(1):21-23. doi: 10.1007/s12020-017-1254-0. Epub 2017 Feb 8. Review.

PMID:
28181143
26.

Modern History of Medical Cannabis: From Widespread Use to Prohibitionism and Back.

Pisanti S, Bifulco M.

Trends Pharmacol Sci. 2017 Mar;38(3):195-198. doi: 10.1016/j.tips.2016.12.002. Epub 2017 Jan 14. No abstract available.

PMID:
28095988
27.

Updates on "adiponcosis": More new incoming evidence strengthening the obesity-cancer link.

Bifulco M, Ciaglia E.

Eur J Intern Med. 2017 Jun;41:e19-e20. doi: 10.1016/j.ejim.2016.12.016. Epub 2016 Dec 27. No abstract available.

PMID:
28038825
28.

Statins for inflammatory bowel disease: Can off-label drug help it?

Bifulco M, Ciaglia E.

Eur J Intern Med. 2017 Mar;38:e23. doi: 10.1016/j.ejim.2016.11.008. Epub 2016 Nov 14. No abstract available.

PMID:
27856092
29.

Brain cancer risk: the weight of obesity.

Bifulco M, Ranieri R, Ciaglia E.

J Neurooncol. 2017 Jan;131(2):421-422. doi: 10.1007/s11060-016-2315-6. Epub 2016 Nov 9. No abstract available.

PMID:
27830478
30.

Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor.

Ciaglia E, Abate M, Laezza C, Pisanti S, Vitale M, Seneca V, Torelli G, Franceschelli S, Catapano G, Gazzerro P, Bifulco M.

Int J Cancer. 2017 Feb 15;140(4):959-972. doi: 10.1002/ijc.30505. Epub 2016 Nov 16.

31.

Dental care and dentistry practice in the Medieval Medical School of Salerno.

Bifulco M, Amato M, Gangemi G, Marasco M, Caggiano M, Amato A, Pisanti S.

Br Dent J. 2016 Jul 22;221(2):87-9. doi: 10.1038/sj.bdj.2016.528.

PMID:
27444600
32.

Endocannabinoid System in Neurological Disorders.

Ranieri R, Laezza C, Bifulco M, Marasco D, Malfitano AM.

Recent Pat CNS Drug Discov. 2016;10(2):90-112. Review.

PMID:
27364363
33.

Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders.

Ranieri R, Marasco D, Bifulco M, Malfitano AM.

Recent Pat CNS Drug Discov. 2016 Jun 19. [Epub ahead of print]

PMID:
27334611
34.

Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response.

Ranieri R, Laezza C, Bifulco M, Marasco D, Malfitano AM.

Recent Pat CNS Drug Discov. 2016;10(2):178-203. Review.

PMID:
27334610
35.

Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders.

Ranieri R, Marasco D, Bifulco M, Malfitano AM.

Recent Pat CNS Drug Discov. 2016;10(2):157-177. Review.

PMID:
27184693
36.

Immuno-Modulatory Properties of a Quinolin-2-(1H)-on-3-Carboxamide Derivative: Relevance in Multiple Sclerosis.

Malfitano AM, Laezza C, Pisanti S, Manera C, Bifulco M.

Recent Pat CNS Drug Discov. 2016;10(2):113-121.

PMID:
27097974
37.

Molecular mechanisms responsible for neuroinflammation and neurological impairments in mevalonate kinase deficiency.

Bifulco M.

Mol Genet Metab Rep. 2015 Apr 2;3:42. doi: 10.1016/j.ymgmr.2015.03.006. eCollection 2015 Jun. No abstract available.

38.

Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation.

Blondel S, Egesipe AL, Picardi P, Jaskowiak AL, Notarnicola M, Ragot J, Tournois J, Le Corf A, Brinon B, Poydenot P, Georges P, Navarro C, Pitrez PR, Ferreira L, Bollot G, Bauvais C, Laustriat D, Mejat A, De Sandre-Giovannoli A, Levy N, Bifulco M, Peschanski M, Nissan X.

Cell Death Dis. 2016 Feb 18;7:e2105. doi: 10.1038/cddis.2015.374.

39.

The new task for medical scientists.

Bifulco M.

Eur J Intern Med. 2016 Apr;29:e21. doi: 10.1016/j.ejim.2015.12.005. Epub 2016 Jan 5. No abstract available.

PMID:
26777105
40.

Breast adiponcosis: a call for further research.

Bifulco M, Malfitano AM.

Endocrine. 2017 Jan;55(1):326-327. doi: 10.1007/s12020-015-0839-8. Epub 2016 Jan 4. No abstract available.

PMID:
26725314
41.

p53 regulates the mevalonate pathway in human glioblastoma multiforme.

Laezza C, D'Alessandro A, Di Croce L, Picardi P, Ciaglia E, Pisanti S, Malfitano AM, Comegna M, Faraonio R, Gazzerro P, Bifulco M.

Cell Death Dis. 2015 Oct 15;6:e1909. doi: 10.1038/cddis.2015.279.

42.

Statin reduces orbitopathy risk in patients with Graves' disease by modulating apoptosis and autophagy activities.

Bifulco M, Ciaglia E.

Endocrine. 2016 Sep;53(3):649-50. doi: 10.1007/s12020-015-0762-z. Epub 2015 Oct 5.

PMID:
26438397
43.

Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells.

Fiore D, Proto MC, Pisanti S, Picardi P, Pagano Zottola AC, Butini S, Gemma S, Casagni A, Laezza C, Vitale M, Ligresti A, Di Marzo V, Zisterer DM, Nathwani S, Williams DC, Campiani G, Gazzerro P, Bifulco M.

Cancer Biol Ther. 2016 Aug 2;17(8):849-58. doi: 10.1080/15384047.2015.1078028.

44.

How does the Mediterranean diet decrease the risk of a variety of cancers?

Bifulco M.

Eur J Clin Nutr. 2015 Dec;69(12):1372. doi: 10.1038/ejcn.2015.142. Epub 2015 Sep 16. No abstract available.

PMID:
26373965
45.

Lung and Nodal Involvement in Nontuberculous Mycobacterial Disease: PET/CT Role.

Del Giudice G, Bianco A, Cennamo A, Santoro G, Bifulco M, Marzo C, Mazzarella G.

Biomed Res Int. 2015;2015:353202. doi: 10.1155/2015/353202. Epub 2015 May 28.

46.

Mediterranean diet: the missing link between gut microbiota and inflammatory diseases.

Bifulco M.

Eur J Clin Nutr. 2015 Sep;69(9):1078. doi: 10.1038/ejcn.2015.81. Epub 2015 May 27. No abstract available.

PMID:
26014263
47.

Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells.

Ciaglia E, Torelli G, Pisanti S, Picardi P, D'Alessandro A, Laezza C, Malfitano AM, Fiore D, Pagano Zottola AC, Proto MC, Catapano G, Gazzerro P, Bifulco M.

Oncotarget. 2015 Jun 20;6(17):15464-81.

48.

New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity.

Manera C, Malfitano AM, Parkkari T, Lucchesi V, Carpi S, Fogli S, Bertini S, Laezza C, Ligresti A, Saccomanni G, Savinainen JR, Ciaglia E, Pisanti S, Gazzerro P, Di Marzo V, Nieri P, Macchia M, Bifulco M.

Eur J Med Chem. 2015 Jun 5;97:10-8. doi: 10.1016/j.ejmech.2015.04.034. Epub 2015 Apr 24.

PMID:
25935384
49.

Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines.

Refolo MG, D'Alessandro R, Malerba N, Laezza C, Bifulco M, Messa C, Caruso MG, Notarnicola M, Tutino V.

J Cell Physiol. 2015 Dec;230(12):2973-80. doi: 10.1002/jcp.25026.

PMID:
25893829
50.

Cannabinoid receptor 1 antagonism in hepatocellular carcinoma: killing two birds with one stone.

Bifulco M, Ciaglia E.

Eur J Gastroenterol Hepatol. 2015 Jun;27(6):747-8. doi: 10.1097/MEG.0000000000000337. No abstract available.

PMID:
25831132

Supplemental Content

Loading ...
Support Center